Status:
UNKNOWN
ABPT in Secondary Pneumothorax With Persistent Airleak Study
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Autologous Blood Patch Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective clinical trial with each patient serving as his/her own control. Patients will be recruited in three different Hong Kong hospital. All patients at the recruitment centers with on...
Detailed Description
The patient must have a chest tube in place and checked to be patent. Approximately 1.5ml/kg of venous blood will be withdrawn from the patient and immediately instilled it into the pleural cavity wit...
Eligibility Criteria
Inclusion
- aged 18 years or older;
- radiographically proven pneumothorax and underlying lung disease (either pre-existing or shown in diagnostic imaging at presentation);
- chest tube inserted which still shows an air leak at day 5 (or later) after the first radiographic evidence of a pneumothorax.
Exclusion
- inability to provide informed consent;
- a chest tube smaller than 12 F (because of the risk of blockage by blood)
- bilateral pneumothorax
- uncorrectable coagulopathy
- active or recent (within 6 weeks) pleural infection
- use of long term steroid or immunosuppressant
- septicaemia or active extrapleural infection (eg pneumonia)
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04132687
Start Date
September 10 2019
End Date
October 30 2020
Last Update
October 22 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong
2
Prince of Wales Hospital
Hong Kong, Hong Kong